Molecular Formula | C17H9NO3 |
Molar Mass | 275.26 |
Density | 1.373±0.06 g/cm3(Predicted) |
Melting Point | >290℃ |
Boling Point | 495.0±48.0 °C(Predicted) |
pKa | -3.87±0.20(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
In vitro study | SJB2-043 causes a dose-dependent decrease in ubiquitin-specific protease 1 (USP1) levels and a concomitant degradation of inhibitor of DNA-binding-1 (ID1) protein in the K562 cells at a micromolar drug concentration. SJB2-043 also causes a decrease in the levels of other ID proteins, namely ID2 and ID3 in K562 cells. SJB2-043 causes a dose-dependent decrease in the number of viable K562 cells, with an EC 50 of approximately 1.07 μM. Moreover, SJB2-043 induces apoptosis of K562 cells in a dose-dependent manner. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.633 ml | 18.165 ml | 36.329 ml |
5 mM | 0.727 ml | 3.633 ml | 7.266 ml |
10 mM | 0.363 ml | 1.816 ml | 3.633 ml |
5 mM | 0.073 ml | 0.363 ml | 0.727 ml |
uses | SJB2-043 is a potent USP1 inhibitor that inhibits the activity of native USP1/UAF1 with an IC50 of 544 nM. |
biological activity | SJB2-043 is a potent inhibitor of USP1, which can inhibit the activity of natural USP1/uaf1, the corresponding IC50 value was 544 nM. |
Target | Value |
USP1-UAF1 (Cell-free assay) | 544 nM |